Literature DB >> 26428057

Sodium tanshinone IIA sulfonate affects Marek's disease virus replication by inhibiting gB expression.

Jin Wang1, Panpan Sun1, Yuning Feng1, Jianhua Guo2, Yaogui Sun1, Haimin Lei3, Jianqin Xu4, Hongquan Li1.   

Abstract

CONTEXT: Previous studies demonstrated that sodium tanshinone IIA sulfonate (STS) could inhibit MDV replication in vitro. The mechanism about how STS inhibits MDV replication is still not well understood.
OBJECTIVE: In this study, we evaluated the effect of STS on gB gene/protein of Marek's disease virus (MDV).
MATERIALS AND METHODS: The concentration of 0.25 mg/ml of STS was used in this study. Meanwhile, 0.25 mg/ml of acyclovir (ACV) was used as a positive control. About 9-11-d-old embryonated specific-pathogen-free (SPF) chicken eggs were used to prepare CEF cells. CEF cells were infected with MDV 2 h, followed by treatment with STS. Real-time PCR and western blot assay were used to measure the gB (UL27) gene/protein expression in STS treatment group at 24, 48, 72, and 96 h post-infection.
RESULTS: Compared with MDV control, the gB gene copies were significantly decreased in STS and ACV treatment groups at 72 h and 96 h (p < 0.05), both in the DNA and in the mRNA level. Furthermore, the expression of gB protein was also inhibited by STS at 24, 72, and 96 h. DISCUSSION AND
CONCLUSION: Our study demonstrated that STS could effectively inhibit the MDV replication by suppressing gB gene/protein expression in cell culture.

Entities:  

Keywords:  Anti-MDV; CEF cells; traditional Chinese medicine

Mesh:

Substances:

Year:  2015        PMID: 26428057     DOI: 10.3109/13880209.2015.1072568

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  1 in total

1.  Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro.

Authors:  Dong-Sheng Ouyang; Wei-Hua Huang; Dan Chen; Wei Zhang; Zhi-Rong Tan; Jing-Bo Peng; Yi-Cheng Wang; Ying Guo; Dong-Li Hu; Jian Xiao; Yao Chen
Journal:  Chin Med       Date:  2016-03-22       Impact factor: 5.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.